Who are Cannabis Bioscience International Holdings, Inc.'s main suppliers?

Cannabis Bioscience International Holdings, Inc. (CBIH) key suppliers include: GEORGE-OPARA, UNRELATED-PARTY-JANUARY-2023, UNRELATED-PARTY-MAY-2022, SBA-EIDL. View the full supplier network at chainsifter.com/chain/CBIH.

Who are Cannabis Bioscience International Holdings, Inc.'s major customers?

Cannabis Bioscience International Holdings, Inc. (CBIH) key customers include: ALPHA-RESEARCH-BUSINESS, COVANCE, GLAXOSMITHKLINE-PLC, ICON-PLC, IQVIA-HOLDINGS-INC and 25 more. View the full customer network at chainsifter.com/chain/CBIH.

What sector is Cannabis Bioscience International Holdings, Inc. in?

Cannabis Bioscience International Holdings, Inc. (CBIH) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Cannabis Bioscience International Holdings, Inc. Supplier List (CBIH): 4 Verified Suppliers

4Suppliers

30Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Cannabis Bioscience International Holdings, Inc. (CBIH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

38Total relationships

4Distinct source URLs

24High confidence

0.830Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Cannabis Bioscience International Holdings, Inc. Suppliers

Ticker	Name	Confidence	Evidence
GEORGE-OPARA	GEORGE-OPARA	92%	On March 20, 2026, the Company entered into an agreement resulting in the issuance of 20,000,000 shares of its common stock to George Opara. The shares were issued as compensation for professional se…
UNRELATED-PARTY-JANUARY-2023	UNRELATED-PARTY-JANUARY-2023	90%	In January 2023, the Company entered into a financing agreement with an unrelated party for a loan of $ 20,000 , bearing interest at the rate of 33.5 % per annum, to be repaid at the rate of $1,874 p…
UNRELATED-PARTY-MAY-2022	UNRELATED-PARTY-MAY-2022	90%	In May 2022, the Company entered into a financing agreement with an unrelated party for a loan of $ 50,000 , bearing interest at the rate of 20.9 % per annum, to be repaid at the rate of $1,218 per w…
SBA-EIDL	SBA-EIDL	85%	The Company has entered into loans under which it borrowed money and financing agreements under which it sold receivables to third parties

Cannabis Bioscience International Holdings, Inc. Customers

Ticker	Name	Confidence	Evidence
ALPHA-RESEARCH-BUSINESS	ALPHA-RESEARCH-BUSINESS	90%	The Company has depended on a few customers of Alpha Research Business for substantial portions of its revenue.
COVANCE	COVANCE	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
GLAXOSMITHKLINE-PLC	GLAXOSMITHKLINE-PLC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
ICON-PLC	ICON-PLC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
IQVIA-HOLDINGS-INC	IQVIA-HOLDINGS-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
MDT	Medtronic plc	90%	Reciprocal relationship from MDT graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from MDT graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from MDT grap…
MEDPACE-HOLDINGS-INC	MEDPACE-HOLDINGS-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
MEDTRONIC-PLC	MEDTRONIC-PLC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
MERCK-CO-INC	MERCK-CO-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
NVS	Novartis AG	90%	Reciprocal relationship from NVS graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from NVS graph: Reciprocal relationship from CBIH graph: Our clients have included Sponsors su…
NVS	Novartis AG	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PAREXEL	PAREXEL	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PFIZER-INC	PFIZER-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PHARMACOLOGY-UNIVERSITY	PHARMACOLOGY-UNIVERSITY	90%	On December 31, 2025, the Company terminated its Pharmacology University business.
PPD-INC	PPD-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
PRA-HEALTH-SCIENCES-INC	PRA-HEALTH-SCIENCES-INC	90%	Our clients have included Sponsors such as Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., Medtronic plc, Novartis, GlaxoSmithKline plc, Gilead Sciences, Inc. and Johnson & Johnson, and CROs, s…
THREE-CUSTOMERS	THREE-CUSTOMERS	90%	The Company had three customers that provided 99 % of gross revenue for the quarter ended November 30, 2025
TWO-CUSTOMERS	TWO-CUSTOMERS	90%	two customers that provided 98 % of gross revenue for the quarter ended November 30, 2024
VITA-BIOTECH-RESEARCH-LLC	VITA-BIOTECH-RESEARCH-LLC	90%	One of our clients is Vita Biotech Research, LLC ("Vita"), which is engaged in data collection for clinical trials.
GILD	Gilead Sciences, Inc.	72%	ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sp…
GILD	Gilead Sciences, Inc.	72%	Reciprocal relationship from GILD graph: Reciprocal relationship from CBIH graph: ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all the…
IQV	IQVIA Holdings Inc.	72%	Reciprocal relationship from IQV graph: Reciprocal relationship from CBIH graph: ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all ther…
IQV	IQVIA Holdings Inc.	72%	ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sp…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CBIH graph: ness Through the Alpha Research Busin…
JNJ	Johnson & Johnson	72%	ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sp…
MDT	Medtronic plc	72%	ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sp…
MEDP	Medpace Holdings, Inc.	72%	ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sp…
MEDP	Medpace Holdings, Inc.	72%	Reciprocal relationship from MEDP graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from MEDP graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from MEDP g…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from MRK graph: Reciprocal relationship from CBIH graph: Reciprocal relationship from MRK grap…
MRK	Merck & Co., Inc.	72%	ness Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sp…

Cannabis Bioscience International Holdings, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CBIH-DEBT	Debt stack $264,092	90%	Market cache reports total debt of $264,092.

Cannabis Bioscience International Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cannabis Bioscience International Holdings, Inc..

Cannabis Bioscience International Holdings, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Cannabis Bioscience International Holdings, Inc..

Cannabis Bioscience International Holdings, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
PSNL	Personalis, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2
ALC	Alcon Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
VEEV	Veeva Systems Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
AVIR	Atea Pharmaceuticals, Inc.	100.00	2
IMMP	Immutep Limited	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2

Cannabis Bioscience International Holdings, Inc. Supply Chain